HOME › DRUGS › LEBRIKIZUMAB-LBKZ
ACTIVE SUBSTANCE / INN

LEBRIKIZUMAB-LBKZ

Brand name(s): EBGLYSS
FDA LISTED
PRESCRIPTION
BLA761306
ACTIVE SUBSTANCE
Lebrikizumab-Lbkz
REGULATORS
FDA
SPONSORS / MAH
ELI LILLY AND CO
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EBGLYSSBLA761306ELI LILLY AND COPrescription

FULL INTELLIGENCE ON LEBRIKIZUMAB-LBKZ

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →